| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.26T | 1.20T | 1.15T | 1.10T | 1.05T |
| Gross Profit | 379.72B | 371.15B | 357.28B | 342.46B | 337.67B |
| EBITDA | 240.80B | 253.42B | 236.61B | 223.18B | 220.31B |
| Net Income | 112.66B | 108.11B | 101.95B | 96.08B | 94.27B |
Balance Sheet | |||||
| Total Assets | 2.23T | 2.15T | 2.08T | 1.99T | 1.91T |
| Cash, Cash Equivalents and Short-Term Investments | 583.55B | 584.63B | 599.15B | 684.18B | 685.86B |
| Total Debt | 68.50B | 72.64B | 68.96B | 64.28B | 67.63B |
| Total Liabilities | 730.44B | 697.84B | 690.09B | 673.01B | 651.72B |
| Stockholders Equity | 1.31T | 1.27T | 1.22T | 1.16T | 1.12T |
Cash Flow | |||||
| Free Cash Flow | 130.00B | 95.20B | 83.00B | 95.66B | 109.75B |
| Operating Cash Flow | 200.48B | 172.74B | 164.28B | 145.44B | 162.86B |
| Investing Cash Flow | -88.59B | -100.77B | -159.34B | -67.60B | -55.28B |
| Financing Cash Flow | -115.04B | -85.28B | -98.42B | -80.68B | -87.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥171.32B | 16.73 | ― | 1.39% | 12.59% | 26.31% | |
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
65 Neutral | ¥573.58B | 16.45 | ― | 2.14% | 8.18% | 23.30% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥4.35B | 6.76 | ― | 3.03% | 14.54% | ― | |
62 Neutral | ¥37.94B | 14.21 | ― | 1.95% | 10.26% | -21.50% |